wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37636802-1B88E668-1F1F-4735-A8A9-B49930EB505F
Q37636802-1B88E668-1F1F-4735-A8A9-B49930EB505F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37636802-1B88E668-1F1F-4735-A8A9-B49930EB505F
A phase II study of concurrent chemoradiotherapy and erlotinib for inoperable esophageal squamous cell carcinoma
P2860
Q37636802-1B88E668-1F1F-4735-A8A9-B49930EB505F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37636802-1B88E668-1F1F-4735-A8A9-B49930EB505F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e4f739d1f3276c82c9039a9efe6e14f74fb7e01a
P2860
Erlotinib after Gefitinib failure in female never-smoker Asian patients with pulmonary adenocarcinoma.